Indeed, recent data by Bengsch et al. [52] using PDA mouse models have demonstrated that blocking CTLA4 in Tregs induces CD4+ T-cell tumor infiltration, suggesting an important role for pancreatic cancer immunotherapy. The gene discussed is CD4; the disease is Patent ductus arteriosus.